×
About 1,002,963 results

First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy
https://clinicaltrials.gov/ct2/show/NCT03798535

Jan 14th, 2022 - This is a non-interventional/observational study including NSCLC unresectable Stage III patients treated with durvalumab. Patient selection and retrospective data collection will be from participating countries: Australia, Belgium, Israel, Netherlands, Norway France, Germany, Italy, Switzerland, Spain Chart abstractions will occur at specified intervals up to five years after the patient had th...

Effects of Cladribine Tablets on the PK of Microgynon®
https://clinicaltrials.gov/ct2/show/NCT03745144

Jan 14th, 2022 - The purpose of this study is to investigate the potential effects of cladribine on the pharmacokinetics (PK) of monophasic oral contraceptive microgynon® by assessment of its constituents, ethinyl estradiol (EE) and levonorgestrel (LNG).

Effect of Research Participation Versus Usual Clinical Treatment on Pain in Patients With Musculoskeletal Disorders
https://clinicaltrials.gov/ct2/show/NCT03785561

Jan 14th, 2022 - Musculoskeletal (MSK) disorders are a major burden on individuals, health systems, and social care systems. Increases in life expectancy and ageing populations are expected to make MSK disorders one of the leading causes of disability by the year 2020. When faced with a potentially life changing diagnosis of a chronic disease, people (in general) develop an organized pattern of perceptions abou...

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
https://clinicaltrials.gov/ct2/show/NCT03740529

Jan 14th, 2022 - This study includes 3 parts: Phase 1 (pirtobrutinib monotherapy dose escalation and dose expansion), Phase 1b (pirtobrutinib combination therapy dose expansion), and Phase 2 (pirtobrutinib monotherapy dose expansion). In Phase 1, patients will be enrolled using an accelerated titration design. The starting dose of pirtobrutinib in oral tablet form is 25 mg/day (e.g., 25 mg once daily [QD]). Onc...

Pilot Simulation RCT of Telemedical Support for Paramedics
https://clinicaltrials.gov/ct2/show/NCT03742167

Jan 14th, 2022 - In the United States, the current standard of pre-hospital (out-of-hospital) emergency care for children with life-threatening illnesses in the community includes remote physician medical direction for paramedics providing life-saving therapies while transporting the child to the hospital. Most pre-hospital emergency medical service (EMS) agencies use radios systems for audio communication betw...

A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease
https://clinicaltrials.gov/ct2/show/NCT03761849

Jan 14th, 2022 - This study will evaluate the efficacy, safety, and biomarker effects of RO7234292 (RG6042) compared with placebo in participants with manifest Huntington's disease (HD).

Improving CarE for Community Acquired Pneumonia
https://clinicaltrials.gov/ct2/show/NCT03760419

Jan 14th, 2022 - Pneumonia is the most common serious infection in childhood. In the United States (US), pneumonia accounts for 1-4% of all emergency department (ED) visits in children (3-28 per 1,000 US children per year) and ranks among the top 3 reasons for pediatric hospitalization with >100,000 hospitalizations per year (15-22 per 100,000 US children per year)2-5. Pneumonia also accounts for more days of a...

A Post-Approval Study of the LINX® Reflux Management System
https://clinicaltrials.gov/ct2/show/NCT01940185

Jan 14th, 2022 - A Post-Approval Study of the LINX® Reflux Management System in a prospective, multicenter, single-arm study, with patients as their own control to monitor the safety and efficacy of the LINX implant procedure and device in a post-approval environment to supplement existing safety and efficacy data.

Screening of Low Responders for Aneuploidy to Improve Reproductive Efficiency
https://clinicaltrials.gov/ct2/show/NCT01977144

Jan 14th, 2022 - Patients will undergo a stimulated IVF cycle culminating with an ultrasound guided egg retrieval procedure and either a fresh or frozen embryo transfer as clinically appropriate and without regard to study. All embryology laboratory procedures will be conducted per routine. Once the embryo(s) have reached the blastocyst stage of development patients will be randomized into either the study grou...

Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart Disease
https://clinicaltrials.gov/ct2/show/NCT03417999

Jan 14th, 2022 - The high anxiety levels that children may experience during the preoperative period may be associated with negative medical, psychological, and social consequences. To reduce this stress, and to facilitate separation from parents and the induction of anesthesia, children are often given a sedative prior to undergoing a procedure. Dexmedetomidine is a highly selective a2-adrenergic receptor agon...

A Follow-up Study of Women Evaluated and Treated for Infertility
https://clinicaltrials.gov/ct2/show/NCT00342446

Jan 14th, 2022 - BACKGROUND: We previously conducted a retrospective cohort study of 12,193 patients evaluated for infertility between 1960-1988 at five clinical sites. Detailed information abstracted from the medical records, along with questionnaires administered to located patients and cancer incidence and mortality data derived from cancer registries and the National Death Index, allowed us to examine cance...

New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in ShangHai
https://clinicaltrials.gov/ct2/show/NCT03533543

Jan 14th, 2022 - In the present study, investigators retrospectively reviewed the medical records of all acute MI patients who were admitted to the coronary artery unit (CCU) of Shanghai Tenth People's Hospital between February 2014 and March 2018. All eligible patients' demographics, cardiovascular risk factors, comorbidities, laboratory tests, echocardiography data, angiography data, acute and dischage medica...

Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety
https://clinicaltrials.gov/ct2/show/NCT02679508

Jan 14th, 2022 - This is a multicenter, open-label, randomized, parallel-group study to exploratorily evaluate the effect on gastric mucosal tissue and the safety of long-term administration of vonoprazan in maintenance treatment after healed EE, and the curative effect of vonoprazan versus lansoprazole in participants with EE. Participants endoscopically diagnosed with EE of Los Angeles (LA) Classification Gra...

Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care
https://clinicaltrials.gov/ct2/show/NCT02679781

Jan 14th, 2022 - Prospective, parallel design Study and control group: 100 healthy children (ASA 1), ages: 2-6 years, uncooperative (Frankl 1-2), that needs at least two similar dental treatments. Exclusion criteria: enlarged tonsils (Brodsky's grading scale11 +3 = 50-75% airway obstruction, and +4 = >75% airway obstruction), upper respiratory tract infection or nasal discharge. Randomization: At the first appo...

Pathological Basis of MRI Signal Changes in Multiple Sclerosis
https://clinicaltrials.gov/ct2/show/NCT02659956

Jan 14th, 2022 - Objective: The goal of this protocol is to understand how the pathology of multiple sclerosis (MS) relates to its evolution over time as observed through neuroradiological, clinical, and biological data collection in vivo. Study population: This study will enroll up to 150 individuals with MS, targeting 50 study completers, across various ages and stages of the disease, as well as 50 appropriat...

Cholinergic Receptor Imaging in Dystonia
https://clinicaltrials.gov/ct2/show/NCT02689466

Jan 14th, 2022 - Dystonia is a heterogeneous group of movement disorders characterized by abnormal muscle contractions resulting in abnormal postures and movements. The spectrum of dystonia includes focal, segmental, multifocal, and generalized presentations with a broad range of age of onset. An example of a focal dystonia is cervical dystonia. The pathophysiology of dystonia is unclear, but prior neuroimaging...

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease
https://clinicaltrials.gov/ct2/show/NCT03599622

Jan 14th, 2022 - The purpose of this study is to assess the safety and effectiveness of BMS-986165 compared to placebo in participants with moderately to severely active Crohn's Disease.

Youth Services Navigation Intervention for HIV+ Adolescents and Young Adults Being Released From Incarceration
https://clinicaltrials.gov/ct2/show/NCT03584932

Jan 14th, 2022 - HIV prevalence among incarcerated youth living with HIV (YLWH) is three times that of the general population and one in seven of all HIV+ persons experience incarceration each year. Furthermore, only an estimated 6% of HIV+ youth achieve HIV viral load suppression, due to poor retention and adherence to anti-retroviral therapy (ART). Existing linkage and retention services are insufficient to m...

Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)
https://clinicaltrials.gov/ct2/show/NCT02624869

Jan 14th, 2022 - The main purpose of this study is to describe the safety and tolerability of 80 weeks of subcutaneous (SC) evolocumab when added to standard of care in children 10 to 17 years of age with familial hypercholesterolemia.

Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
https://clinicaltrials.gov/ct2/show/NCT03473223

Jan 14th, 2022 - This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation myocardial infarction (STEMI) or non-ST...